| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |